Enveric Biosciences, Inc. Logo

Enveric Biosciences, Inc.

Develops novel small-molecule therapeutics for neuropsychiatric disorders.

ENVB | US

Overview

Corporate Details

ISIN(s):
US02362F3029 (+1 more)
LEI:
Country:
United States of America
Address:
245 FIRST STREET RIVERVIEW II 18TH FLOOR, 2142 CAMBRIDGE

Description

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-12 18:10
8-K
English 393.1 KB
2025-12-11 18:41
8-K
English 72.0 KB
2025-12-10 21:47 English 8.6 KB
2025-12-10 21:47 English 8.8 KB
2025-12-10 02:08
424B3
English 72.2 KB
2025-12-09 06:15 English 5.2 KB
2025-12-06 01:06 English 8.8 KB
2025-12-05 23:40 English 8.9 KB
2025-12-05 23:18
S-3/A
English 102.2 KB
2025-11-14 22:31
10-Q
English 912.7 KB
2025-11-14 22:05
8-K
English 64.2 KB
2025-11-14 22:05
8-K
English 96.7 KB
2025-11-13 21:42 English 9.6 KB
2025-10-27 21:30
DEF 14A
English 1.4 MB
2025-10-23 22:30
8-K
English 112.7 KB

Automate Your Workflow. Get a real-time feed of all Enveric Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enveric Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enveric Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Evotec SE Logo
A life science company offering drug discovery and development partnership solutions.
Germany
EVT
EXICURE, INC. Logo
Early-stage biotech developing nucleic acid therapies based on SNA technology.
United States of America
XCUR
EyeGene,Inc Logo
Develops gene/cell therapies for age-related diseases and preventive vaccines.
South Korea
185490
Femtobiomed Inc. Logo
Develops a non-viral intracellular delivery platform for cell and gene therapy.
South Korea
327610
Develops AI data center campuses with co-located hybrid power generation.
United States of America
FRMI
Fluicell AB Logo
A biotech firm creating engineered tissues for regenerative medicine and drug development.
Sweden
FLUI
Foghorn Therapeutics Inc. Logo
Develops medicines targeting the chromatin regulatory system for oncology.
United States of America
FHTX
Fortrea Holdings Inc. Logo
A global CRO providing clinical development and patient access solutions to life sciences.
United States of America
FTRE
FUSION ANTIBODIES PLC Logo
CRO providing end-to-end services for preclinical antibody development.
United Kingdom
FAB
Genenta Science S.p.A. Logo
Clinical-stage developer of hematopoietic stem cell gene therapies for immuno-oncology.
United States of America
GNTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.